will compound tirzepatide end Compounded Crisis! Patients Left Scrambling as FDA Ends Shortage will tirzepatide no longer be

By Ike Swetlitz and Madison Muller | Bloomberg The first dose of a copycat weight-loss drug Lindsay Posey took from a new pharmacy worked well

Knowing what to expect and when helps you stay confident in your treatment plan

Even if the most likely explanation is a known medication effect, ruling out other causes is important

Conclusions The current study revealed that semaglutide, as an adjunct to AID in T1D patients, particularly in those with higher BMI, caused greater weight loss and higher glycemic benefits

Strategic dietary modifications can substantially reduce the severity and frequency of these symptoms, improving treatment adherence and quality of life